Drug
Brilacidin
Brilacidin is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Phase Distribution
Ph phase_1
1
25%
Ph phase_2
3
75%
Phase Distribution
1
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
3(75.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (25.0%)
Phase 23 (75.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_2
A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19
NCT04784897
completedphase_1
A Study to Investigate the Use of Delayed Release Tablets for Colonic Delivery of Brilacidin in Healthy Volunteers
NCT04240223
completedphase_2
Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer
NCT02324335
completedphase_2
Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
NCT02052388
Clinical Trials (4)
Showing 4 of 4 trials
NCT04784897Phase 2
A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19
NCT04240223Phase 1
A Study to Investigate the Use of Delayed Release Tablets for Colonic Delivery of Brilacidin in Healthy Volunteers
NCT02324335Phase 2
Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer
NCT02052388Phase 2
Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4